earnings

NASDAQ · LXRX
Lexicon Pharmaceuticals, Inc.
Healthcare · Biotechnology
$1.65
Down-$0.03 (-1.79%)
Updated Oct 13, 2026, 8:29 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 481.5M
- P/E ratio
- -3.99
- Dividend yield
- 0.00%
- 52-week range
- $1.49 – $2.68
- Volume
- 2.03M
- Avg. volume
- 2.31M
Price performance · LXRX
LXRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 12, 2026
LXRX closed at $1.65 after 21 trading sessions, down 16.67% for the selected period.
- Last close
- $1.65
- Period change
- -16.67%
- Period low
- $1.65
- Period high
- $2.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | $1.65 | $1.67 | $1.605 | $1.65 | 2.03M |
| Oct 9, 2026 | $1.75 | $1.77 | $1.67 | $1.68 | 2.07M |
| Oct 8, 2026 | $1.75 | $1.78 | $1.695 | $1.76 | 3.32M |
| Oct 7, 2026 | $1.73 | $1.77 | $1.7137 | $1.76 | 1.1M |
| Oct 6, 2026 | $1.75 | $1.78 | $1.72 | $1.75 | 1.64M |
| Oct 5, 2026 | $1.83 | $1.83 | $1.72 | $1.74 | 2.72M |
| Oct 2, 2026 | $1.85 | $1.87 | $1.80 | $1.82 | 2.32M |
| Oct 1, 2026 | $1.86 | $1.87 | $1.81 | $1.82 | 2.27M |
| Sep 30, 2026 | $1.89 | $1.95 | $1.8435 | $1.875 | 1.74M |
| Sep 29, 2026 | $1.92 | $1.94 | $1.80 | $1.88 | 3.95M |
| Sep 28, 2026 | $1.88 | $2.05 | $1.81 | $1.90 | 10.89M |
| Sep 25, 2026 | $1.87 | $1.93 | $1.765 | $1.795 | 3.05M |
| Sep 24, 2026 | $2.05 | $2.06 | $1.85 | $1.86 | 4.44M |
| Sep 23, 2026 | $2.17 | $2.17 | $2.02 | $2.06 | 3.17M |
| Sep 22, 2026 | $2.05 | $2.195 | $2.022 | $2.18 | 4.84M |
| Sep 21, 2026 | $2.05 | $2.0775 | $2.00 | $2.04 | 2.51M |
| Sep 18, 2026 | $2.04 | $2.06 | $1.99 | $2.05 | 7.46M |
| Sep 17, 2026 | $2.05 | $2.11 | $2.015 | $2.035 | 2.24M |
| Sep 16, 2026 | $2.01 | $2.055 | $2.00 | $2.02 | 2.15M |
| Sep 15, 2026 | $1.98 | $2.02 | $1.885 | $2.01 | 2.51M |
| Sep 14, 2026 | $1.97 | $2.01 | $1.935 | $1.98 | 1.77M |
Latest LXRX news
The latest Smart Investors Daily articles mentioning LXRX.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

